Treatment of Recurrent Oral Ulcers
Start with topical corticosteroids as first-line therapy for recurrent oral ulcers, progressing to systemic treatments only for refractory cases that fail to respond to topical measures. 1
Initial Topical Treatment Approach
The management of recurrent oral ulcers should follow a stepwise algorithm based on severity and response to treatment:
First-Line Topical Therapies
For localized, accessible ulcers:
- Apply clobetasol gel or ointment 0.05% directly to dried ulcers 2-4 times daily 1
- Alternatively, use triamcinolone acetonide 0.1% paste applied to dried ulcer 2-4 times daily 1
For widespread or difficult-to-reach ulcers:
- Use dexamethasone mouth rinse (0.1 mg/ml) as a rinse-and-spit preparation 1
- Alternatively, betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water used as rinse-and-spit 2-4 times daily 1, 2
Adjunctive Symptomatic Measures
Pain control is essential and should be implemented alongside corticosteroids:
- Apply viscous lidocaine 2% before meals for topical anesthesia 1, 2
- Use benzydamine hydrochloride rinse or spray every 3 hours, particularly before eating 1, 2
- Consider amlexanox 5% oral paste for severe pain 1
Oral hygiene and barrier protection:
- Clean mouth daily with warm saline mouthwashes or sodium bicarbonate rinses 4-6 times daily 1, 2
- Use antiseptic oral rinses twice daily (0.2% chlorhexidine digluconate or 1.5% hydrogen peroxide) 1
- Apply mucoprotectant mouthwashes (Gelclair or Gengigel) three times daily 1, 2
Second-Line Treatment for Refractory Cases
When topical therapy fails after 1-2 weeks, escalate treatment systematically:
Intralesional Corticosteroids
Systemic Corticosteroids
- For highly symptomatic or recurrent ulcers: prednisone/prednisolone 30-60 mg or 1 mg/kg for 1 week, then taper over the second week 1, 2
- This approach is particularly important for severe cases affecting quality of life 3
Alternative Systemic Agents
- Colchicine should be the preferred first-line systemic therapy, especially when erythema nodosum or genital ulcers coexist 3, 1, 2
- Tacrolimus 0.1% ointment applied twice daily for 4 weeks can be effective for recalcitrant cases 1, 2
Third-Line Immunosuppressive Therapy
For resistant cases that fail conventional treatments:
- Azathioprine 2.5 mg/kg/day is effective in preventing mucocutaneous lesions 3, 1
- Interferon-alpha has shown significant improvement in mucocutaneous lesions in RCTs 3
- TNF-alpha antagonists (such as etanercept) should be reserved for the most resistant cases 3, 1
- Apremilast may be considered in selected cases 1
Important Clinical Pitfalls to Avoid
Premature tapering of corticosteroids before disease control is established leads to treatment failure 1
Distinguish recurrent aphthous stomatitis from herpes simplex virus infection:
- Herpes typically affects keratinized mucosa (lips, hard palate, gingiva) and requires antiviral therapy 2
- Aphthous ulcers occur on non-keratinized mucosa (buccal mucosa, tongue, soft palate) 2
Refer to specialist for:
- Ulcers lasting more than 2 weeks 1
- Ulcers not responding to 1-2 weeks of treatment 1
- Suspicion of malignancy or systemic disease 1
Special Considerations for Behçet's Disease
If Behçet's disease is diagnosed, treatment should be tailored to quality of life impact:
- Start with topical corticosteroids and colchicine 3
- Sucralfate suspension has RCT evidence for oral and genital ulcers 3
- Progress to azathioprine, interferon-alpha, or TNF-alpha antagonists for resistant mucocutaneous findings 3
- Avoid ciclosporine A in patients with neurological involvement due to neurotoxicity risk 3
Supportive Lifestyle Modifications
Dietary and environmental modifications reduce ulcer frequency: